---
category: news
title: "AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)"
excerpt: "AI Therapeutics, Inc., an AI driven clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced the acquisition of EntreChem, S.L.â€™s investigational drug candidate EC-8042 (redesignated AIT-102),"
publishedDateTime: 2022-04-25T14:32:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/science-technology-health-business-biology-a152fe18804c16b23cbe4cc35d8bc155"
webUrl: "https://apnews.com/press-release/globe-newswire/science-technology-health-business-biology-a152fe18804c16b23cbe4cc35d8bc155"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI

secured: "KxxygQp/NtqGSQ9xtg/QKIn0lQ22SzUmUp0WPjPuW5KIrhnwmXAN+6p0Mt9/vfV978FIRA+OzKV1or8w2pVI3YoI+Mka/qV7q12KP1fYthSemRpq4arIP0OEQ7mweeRRuP7wCxQ6lyO6OVigUuCD4NFdxKvFnSvvLPbOAiKQdtk6jOZ90cWtyG697raft4RP8JTocVlSQpiWqZ3FiKgGulSZAxaTLhj3OLImJerz6VhqIZMCMKEjDa2qtJQKwsKdatUkfTNLcZ/BFhaDV3EWXQgLbK7im1gsB/TINMsHF4rM3XJQkqflExId70HY/+gOIaecXszvKDnl3KcEes5lNGgdkMw0jeLoXLYJu5J9K2o=;uBvl9aMC3XJyQHkkHH2T+A=="
---

